Sutro Biopharma (STRO) Selling, General & Administrative (2017 - 2026)
Sutro Biopharma (STRO) posted Selling, General & Administrative of $7.83 million for Q2 2026, down 24.3% from $10.34 million a year earlier.
Sutro Biopharma (STRO) Selling, General & Administrative (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Sutro Biopharma was $35.58 million, down 24.3% year-over-year; for FY2025, it was $41.02 million, down 15.3% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of 2.2% (FY2020 to FY2025).
- In prior years, Sutro Biopharma's Selling, General & Administrative was $48.45 million in FY2024 (-22.6%), $62.58 million in FY2023 (+5.1%), $59.54 million in FY2022 (+6.3%) and $56 million in FY2021 (+52.1%).
- The Q2 2026 figure stands as the lowest quarterly Selling, General & Administrative since Q1 2019.
- On a year-over-year basis, Selling, General & Administrative increased in 1 of the last seven quarters, with an average decline of 18.8%.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2021, with growth of 82.7%; the weakest was Q4 2024, with a decline of 46.3%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Sutro Biopharma | 175.16 Mn | -500.76 Mn | - | 7.83 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.83 Mn |
| Dec 31, 2025 | 8.66 Mn |
| Sep 30, 2025 | 8.74 Mn |
| Jun 30, 2025 | 10.34 Mn |
| Mar 31, 2025 | 13.27 Mn |
| Dec 31, 2024 | 9.03 Mn |
| Sep 30, 2024 | 14.33 Mn |
| Jun 30, 2024 | 12.37 Mn |
| Mar 31, 2024 | 12.72 Mn |
| Dec 31, 2023 | 16.80 Mn |
| Sep 30, 2023 | 15.27 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Mar 31, 2023 | 15.51 Mn |
| Dec 31, 2022 | 14.72 Mn |
| Sep 30, 2022 | 14.64 Mn |
| Jun 30, 2022 | 15.14 Mn |
| Mar 31, 2022 | 15.04 Mn |
| Dec 31, 2021 | 15.76 Mn |
| Sep 30, 2021 | 16.59 Mn |
| Jun 30, 2021 | 12.55 Mn |
Sutro Biopharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=STRO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();